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ABSTRACT 
Aim: The purpose of this study was to evaluate the effect of intravenous Clonidine hydrochloride on hemodynamic 
changes associated with laryngoscopy and pin head-holder application in patients undergoing craniotomies. 
Method: Fifty, adult patients of ASA grade I & II were included in this study and divided in two groups of 25 each. 
Group-I patients received 5 ml of normal saline 10-15 minutes before induction while in group-II injection 
Clonidine hydrochloride 2 mcg/kg was given. We observed mean blood pressure and heart rate at 1, 3 and 5 minutes 
after laryngoscopy and application of pin head- holder. We also studied intraoperative events and postoperative side 
effects. Results: Increase in heart rate and blood pressure during laryngoscopy and pin insertion was attenuated by 
Clonidine hydrochloride (P< 0.001). The number of patients developed hypertension were more in control group 
than Clonidine group and required another drug to stabilize the hypertensive response. Two patients in Clonidine 
group developed bradycardia but treated with drug. Conclusion: We concluded that intravenous Clonidine 
hydrochloride given in the dose of 2 mcg/kg was safe and appropriate as a premedication drug for adequate control 
of heart rate and blood pressure thus, maintaining intracranial pressure for neurosurgical anesthesia. 
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Introduction 
 
 
Anesthesia for craniotomy presents special 
considerations .The brain is enclose in a rigid skull and 
the majority of craniotomies are perform for the 
treatment of space occupying lesions. At the same 
time, the brain is a vascular organ presenting potential 
for massive perioperative hemorrhage. Tolerance of the 
brain to interruption of substrate delivery is minimal. 
Maintenance of adequate blood flow to the brain is of 
fundamental importance in neuroanesthesia. In the 
Presence of a space-occupying lesion, the brain has 
limited compensatory ability before intracranial 
pressure (ICP) increases. During this time even minute 
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increase in ICP may lead to displacement of brain 
tissue and cerebellar tonsillar herniation. As the ICP 
depends on MAP, we anesthesiologists’ play a very 
important role in maintaining the ICP throughout the 
surgery by controlling the MAP. The skull pin head 
holder used to secure the head produces an intense 
nociceptive stimulus when applied and results in abrupt 
increases in blood pressure and intracranial pressure [1]. 
Anesthetic and physiologic factors controlled by the 
anesthesiologist have profound effects on the brain. 
Interactions between anesthesia and surgical outcome 
can be expected. Maintenance of stable hemodynamic 
during anesthesia for intracranial surgery is essential to 
optimize cerebral perfusion and to prevent acute 
increases in ICP. Many different approaches have been 
used with varying success to prevent the acute 
increases in blood pressure often seen in association 
with the stimulation of intubation and pin head-holder 
application [2]. 
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The centrally acting α2-agonist Clonidine decreases 
hemodynamic responses to painful stimuli during 
anesthesia, anesthetic requirements and the stress 
response to surgery. Injection Clonidine is well suited 
as a premedication for neurosurgery. The present study 
was designed to assess the effects of intravenous 
Clonidine hydrochloride on hemodynamic changes 
during laryngoscopy and pin head-holder application 
that affect intracranial pressure during craniotomy. We 
also studied safety and efficacy of the drug.  
 
Method 
 
This study was conducted after the permission of 
ethical committee and after taking informed consent of 
50 patients of age group of 18-70 year, weighing 40-
108 kg and ASA grade I and II who were posted for 
craniotomy. Patients allergic to protocol drugs, on 
regular antihypertensive drugs, with infratentorial 
tumor, tumor near brainstem, intracranial pathology 
causing alteration in conscious state and patients taking 
nimodipine therapy were excluded from the study. All 
the patients were subjected for physical and systemic 
examination preoperatively. Routine investigation like 
complete blood count, renal function test, liver function 
test, blood glucose, serum electrolytes, and 
electrocardiogram, chest X-ray, HIV and HBsAg were 
done. Patients were randomly allocated in two groups, 
of 25 each. Group A patients received injection normal 
saline 5 ml while in group B injection Clonidine 
hydrochloride 2mcg/kg was given 10-15 minutes 
before induction (A dilution of 15 mcg/ml). All 
patients were given their regular medications. No 
sedative premedication was used. After taking into the 
operation theatre, vital sign monitor was attached to the 
patient and baseline heart rate, blood pressure, Spo2, 
EtCO2 and respiratory rate were measured. Pre 
oxygenation was done. All patients were induced with 
injection glycopyrrolate 0.2 mg, injection fentanyl 
citrate 4mcg/kg, injection thiopentone sodium 5mg/kg 
intravenously. Oral intubation was done with 
appropriate size flexometallic cuff tube after injection 
vecuronium bromide 0.1mg/kg. Patients were 
maintained with 50% oxygen, 50% nitrous oxide, 
sevoflurane and injection vecuronium bromide 
1mcg/kg/minute as an infusion. Muscle relaxation was 
reversed with injection glycopyrrolate 0.4mg and 
injection neostigmine bromide 0.05mg/kg. To assure 
comparability between the groups, the intubation was 
graded by the authors as 
1 = easy and quick 2 = requiring manipulation or 
additional instrumentation 3 = difficult, requiring 
repeated or prolonged attempts 
Hemodynamic interventions were done according to 
the following protocol 
Hypotension, defined as SBP >20% below the 
preoperative reading, was treated by using bolus of 
lactated Ringer’s solution intravenously or 3mg 
injection mephentermine if more profound or 
prolonged hypotension. Hypertension, defined as SBP 
>30% above baseline, was treated by using injection 
propofol 0.5mg/kg. Bradycardia, defined as HR < 60 
bpm was treated with injection glycopyrrolate or 
injection atropine. Hemodynamic variables were 
allowed to stabilize after any interventions before 
intubation or pin head-holder application. Systolic 
blood pressure (SBP), mean blood pressure (MAP), 
heart rate (HR), SpO2 and EtCO2 were measured 
before induction followed by 1 minute, 3 minutes and 5 
minutes each after laryngoscopy and pin head-holder 
application. Intraoperative adverse events like 
hypotension, hypertension, bradycardia, arrhythmias 
were recorded along with interventions undertaken to 
correct them. In the postoperative period for 24 hours 
the patients were monitored carefully for signs of 
hypoxia, cyanosis, raised ICP, vomiting, pain, 
shivering and sedation (sedation was graded as 1= 
awake and communicative, 2= awake but drowsy, 3= 
asleep but easily roused and 4= unarousable). 
Calculation: - Results for parametric data were reported 
as Mean ± SD. The resultant data between groups was 
analyzed by using unpaired student’s t-tests whereas Z 
test was used to analyze data within groups. Intubation 
and pin head-holder application was analyzed as 
independent events. A p value of <0.05 was significant. 
 
Result 
 
The characteristics of patients in two groups were 
comparable in terms of age, gender, weight, heart rate, 
blood pressure and intubation score (Table-1). 
 
Table 1: Patients characteristics 
 
 Group-A Group-B P value 
Age(years) 44.4 +/- 14.06 46.48 +/- 16.36 0.58 
Weight(kg) 62.6 +/- 11.4 60.6 +/- 11.4 0.45 
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Sex(M/F) 18/7 20/5 1 
Heart rate(bpm) 78.84 +/- 6.7 78.12 +/- 6.31 0.58 
SBP(mm of Hg) 125.44 +/- 8.6 126.88 +/- 8.5  0.55 
Intubation score(1-3) 1 1 1 
                                                            
Table 2: Heart rate changes 
 
 Heart rate per min. Group- A Group- B P value 
 
Baseline 78.84 +/- 6.71 78 +/- 6.31 0.65 
Laryngoscopy 1 minute 82.78 +/- 7.05 82.81 +/- 6.69 0.98 
 
3 minute 96 +/- 8.19 85.93 +/- 6.95 <0.001 
 
5 minute 109 +/- 9.20 87 +/- 7.07 <0.001 
Pin head holder 1 minute 89.88 +/- 7.65 84 +/- 6.76 <0.001 
 
3 minute 98 +/- 8.32 87 +/- 7.01 <0.001 
 
5 minute 102 +/- 8.73 88 +/- 7.13 <0.001 
 
This table shows heart rate changes. In control group heart rate increased both during laryngoscopy and pin head-
holder application while in clonidine group it remains unchanged and statistically significant. 
 
Table 3: Mean arterial pressure changes 
 
 Mean arterial 
pressure changes 
mm of Hg 
Group- A Group- B P value 
 
Baseline 95 +/- 6 93.55 +/- 5.69 0.38 
Laryngoscopy 1 minute 102 +/- 6.42 98.15 +/- 5.98 <0.001 
 
3 minute 112 +/- 7.08 101.03 +/- 6.26 <0.001 
 
5 minute 125 +/- 7.56 110 +/- 6.71 <0.001 
Pin head holder 1 minute 103 +/- 6.48 98.22 +/- 5.97 0.052 
 
3 minute 109 +/- 6.9 104.45 +/- 6.55 <0.001 
 
5 minute 120 +/- 7.56 109 +/- 6.66 <0.001 
 
In this table mean arterial pressure increased in control group than clonidine group (p < 0.005). MAP increased 
maximum at 5 minutes from 95 +/- 6 to 125 +/- 7.56 after laryngoscopy and 120 +/- 7.56 after pin head holder 
application in control group, while in clonidine group it increased from 93.55 +/- 5.69 to 110 +/- 6.71 and 109 +/- 
6.66 each.  
Table 4:No. of patients requiring intervention and amount of drugs use 
 
Drugs Group- A No. of pts. Group- B No.of pts. P value 
Fluid bolus(ml) 100 +/- 39.51 2(8%) 121 +/- 57.64 8(32%) 0.580 
Propofol(mg) 90 +/- 23.12 25(100%) 49 +/- 24.38 6(24%) <0.001 
Glycopyrrolate(mg) 0 0 0 +/- 0.04 2(8%) 1 
 
The number of patients developing hypertension during 
laryngoscopy and pin head-holder application in group 
A was significant.Propofol was given to all patients in 
group A whereas in group B, only 6 patients were 
given which was statistically significant. The amount 
of propofol given also differed in both groups that 
show that the patients pre-treated with Clonidine did 
not develop as much hypertension as the patients in 
control group. In comparing for hypotension, a larger 
proportion of patients developed hypotension in group 
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B. Fluid bolus was given to 8% patients in group A as 
compared to 32% in group B.  No patients required 
injection mephentermine for hypotension. When 
bradycardia was compared, it was seen in only 2 
patients in the Clonidine group and the maximum 
decrease in HR was up to 55bpm and treated with inj. 
glycopyrrolate.  In group A, no patient developed 
bradycardia. As we also recorded ECG changes and 
observed that only 1 patient in group A, developed 
arrhythmia in the form of occasional atrial premature 
complexes that subsided spontaneously in a 2-3 
minutes. In postoperative care unit we saw that none of 
the patient developed hypoxia or cyanosis due to 
respiratory depression. Nausea and vomiting due to 
raised ICP or side effect of various anesthetic drugs 
were not seen. We observed that only 1 patient in 
group A and 2 patients in group B had developed 
bradycardia which was treated with injection 
glycopyrrolate. In group A 15patients and 12patients in 
group B (p=0.39) had a sedation score of 1, 10 patients 
in group A and 12 patients in group B had a sedation 
score of 2 while only 1 patient had a score of 3 in 
group B.  As all the p values were more than 0.05 is 
statically insignificant. 
 
Discussion 
 
Control of hemodynamic parameters during 
neurosurgical procedures is of great concern to the 
neuroanesthesiologist whose goals include ensuring 
optimal cerebral perfusion pressure. Clonidine appears 
to possess many properties that make it an appealing 
adjunct to the Intraoperative management of 
neurosurgical patients [1]. The present study was 
randomized controlled demonstrated that 
hemodynamic changes associated with laryngoscopy 
and pin insertion in patients undergoing craniotomy 
can be ameliorated more efficiently when Clonidine 
was used as intravenous premedication. Mean age of 
both groups were close to each group. Baseline weight, 
pulse and mean pressure were also showed a 
significant similarity between each group.  
Intravenous route was chosen to provide exact drug 
dosing and the gap between administration of drug and 
induction of patients. A gap of 10-15 minutes was 
chosen because onset of action of intravenous 
Clonidine is 2-28 minutes. An average of 15 minutes 
was taken. Costello et al [2] used oral Clonidine while 
Farve et al[ 3] administered Clonidine 3 mcg/kg 10 
minutes before surgery. The dose, route of 
administration and time interval was similar to our 
study. In our study the MAP showed an increase during 
both laryngoscopy and pin head-holder application in 
both the groups. However, in the placebo group the 
average MAP rise was higher during both 
laryngoscopy and pin head-holder application than 
clonidine group. Selina F et al[4] noted the MAP of the 
experimental group decreased steadily throughout the 
perioperative period, while in control group plateau 
reached up to 107 mm of Hg. at the time of burr hole 
and then gradually declined. It was proved that study 
group was better. According to W. Scott Jellish et al 
fluctuation of MAP was minimal [1]. Dorothee et al 
noted that patients treated with Clonidine had lower 
values of MAP than patients with placebo[5].Oral 
Clonidine premedication in craniotomy a study 
conducted by Traill et al noted that in Clonidine group 
lower SBP on arrival in the operative room, 
preinduction and post intubation than control 
group[6].On comparison between the two groups at the 
various intervals we found that except from one 
reading (1min after laryngoscopy) all the time there 
was a significant difference in HR between the two 
groups. Maximum increase in average HR was seen 
5min after laryngoscopy, when the mean HR increased 
by 46.84% ± 8.8% in group A and 26.16% ± 6.67% in 
group B. The difference in HR between the two groups 
was 22 ± 2.19 that was highly significant (p<0.001). 
Selina F et al[4] in their study observed that just after 
intubation the rise in HR between the two groups was 
not statistically significant but once incision was made 
increased in HR was very significant until 60min after 
dura opening.  The pulse rate of Clonidine group was 
maintained within normal range throughout the 
intraoperative period. Bradycardia was noticed in 50% 
patients in the high-dose group, 10% in the low-dose 
group, and in 5% in the placebo group [8]. In our study 
only 8% patient’s developed bradycardia. Scott Jellish 
in their study shows that baseline heart rate was lower 
in patients who received Clonidine. Combination of 
oral Clonidine and lidocaine scalp injection at pin H-H 
sites blunted the blood pressure and heart rate response 
[1]. Dorothee [5] noted that patients treated with 
clonidine had lower values of heart rate from the 
preinduction to the early postanesthesia recovery 
periods than patients who had received placebo. They 
studied endocrine effect and noted that plasma cortisol 
and aldosterone concentration was also decreased. 
Devendra Gupta[7] studied oral atenolol and Clonidine 
premedication on cardiovascular response to nasal 
speculam insertion and stated that heart rate increased 
on speculam insertion in control group, while no 
changes in atenolol and clonidine group. They also 
noted that 10 out of 22 patients in control group 
developed hypertension as compared to only 2 in each 
clonidine and atenolol groups.Fentanyl requirement in 
control group was 136.9±77.6mcg/kg/hr as compared 
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to clonidine group 73.8±36.6mcg/kg/hr and atenolol 
group 70.8±28.7mcg/kg/hr. that is statistically 
significant. Propofol requirement was also greater in 
the control group 143.08±53.29mcg/kg/hr whereas in 
clonidine group it was 119.23±20.80mcg/kg/hr and 
118.42±22.67mcg/kg/hr in atenolol group. Bradycardia 
was seen in 2 patients in atenolol group without 
hypotension that responded to atropine. This establishes 
that the adverse events in our study were like theirs. 
KritonFilos et al[8] studied 2 doses of clonidine 2-
2.5mcg/kg and 4-4.5mcg/kg with a placebo. In the low-
dose group the maximum decrease of MAP ranged 
between 18-19%, whereas in the high dose ranged 
between 25-34%. In the high dose group 30% of patients, 
but none in the low-dose group or in the placebo group 
were treated for hypotension. 65% patients experienced an 
increase in MAP >115 mm Hg throughout the study 
period, whereas no patient in the clonidine treated groups 
exhibited a MAP increase. 
 Hence, our study showed that those patients not pre-
medicated with Clonidine required another drug to 
stabilize the hypertensive response during laryngoscopy 
and pin head-holder application. Saline requirement was 
greater in the Clonidine group but it was not very 
significant though it was seen that the extent of 
hypotension was not very substantial as the SBP never 
decreased below 85mm Hg. 
Samantaray A et al[9] observed the average pain score 
was less in the clonidine. As our study gave an 
insignificant p value (p>0.05), it was postulated that it 
could be because their dose was higher (3mcg/kg) as 
compared to ours (2mcg/kg). Their results on bradycardia 
were similar to our study. The average sedation score 
revealed p= 0.74 and respiratory depression gave p=0.73. 
This result is also parallels to our study as p values for the 
sedation score was always more than 0.05. 
As a result of this study we believed that intravenous 
Clonidine given in the dose of 2mcg/kg 10min before 
induction is appropriate and safe as a premedication drug. 
 
Conclusion 
 
We concluded that preoperative intravenous clonidine 
hydrochloride in a dose of 2mcg/kg 10-15 minutes before 
induction was very effective in controlling fluctuations in 
heart rate and blood pressure during laryngoscopy and pin 
head-holder application in craniotomy patients. It also 
produces stable hemodynamic throughout the surgery. 
Clonidine hydrochloride was safe in terms of 
hemodynamic parameters like overt bradycardia and 
hypotension in the given dose. 
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